EU SEP regulation reveal; PTAB reform reactions; IPBC Global speakers; Ravgen assertion campaign; carmaker litigation data; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.
MONDAY 24 April
Active case management and the role of boutique patent firms in pan-European disputes. Read more here
Data dive: US patent litigation against top automakers rose 32% in 2022. Read more here
TUESDAY 25 April
Amgen’s Federal Circuit victory vindicates $13.4 billion Otezla IP acquisition. Read more here
300 million reasons why patent owners love litigating in Texas. Read more here
New draft European Commission SEP regulation shows tweaks but no rewrite. Read more here
WEDNESDAY 26 April
Ravgen continues winning streak in big-money patent assertion campaign. Read more here
PTAB experts react to discretionary denial reform package. Read more here
THURSDAY 27 April
Weekly column: Chinese IP theft is a problem, but is not to blame for US tech woes. Read more here
Commissioner Breton takes aim at “bad faith” patent licensors as final SEP policy proposal released. Read more here
Xiaomi, Meta and Sisvel to speak at IPBC Global 2023. Read more here
FRIDAY 28 April
European Commission proposes unitary SPC as part of mixed bag of pharma IP reforms. Read more here
US PTAB reform proposal comes under fire at House hearing. Read more here
SATURDAY 29 April
Opinion: Some gold nuggets for patentees in the PTAB reform proposal. Read more here